Takeda Discontinues TAK-128 Clinical Program For Peripheral Diabetic Neuropathy
Japanese firm simultaneously announces that it has inked a monoclonal antibody discovery deal with Xoma.
Japanese firm simultaneously announces that it has inked a monoclonal antibody discovery deal with Xoma.